Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

Salvatore Petta, S. Fagiuoli, Pierluigi Russo et al.|˜The œLancet. Gastroenterology & hepatology|2017

Cited by 19